

(Alliance News) - Stock prices in London were higher at midday on Monday, as investor sentiment was lifted by the news that a US bank will buy more US...


(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.


(Alliance News) - ImmuPharma PLC on Monday said it submitted a phase 2/3 clinical trial protocol to the US Food & Drug Administration testing the Lupu...


(Alliance News) - ImmuPharma PLC on Monday said it has signed an initial collaboration agreement with Orano SA for its peptide technology.


(Alliance News) - ImmuPharma PLC on Monday confirmed alongside its partner Avion Pharmaceuticals that a phase 2/3 adaptive trial will be the best desi...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:


(Sharecast News) - Drug discovery and development specialist ImmuPharma updated the market on a recent meeting in Atlanta with its United States partn...